Core Scientific Statistics
Share Statistics
Core Scientific has 279.25M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 279.25M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 410.49K |
| FTD / Avg. Volume | 3.78% |
Short Selling Information
The latest short interest is 29.49M, so 10.56% of the outstanding shares have been sold short.
| Short Interest | 29.49M |
| Short % of Shares Out | 10.56% |
| Short % of Float | 12.37% |
| Short Ratio (days to cover) | 3.09 |
Valuation Ratios
The PE ratio is -5.3 and the forward PE ratio is 55.03.
| PE Ratio | -5.3 |
| Forward PE | 55.03 |
| PS Ratio | 2.6 |
| Forward PS | 6.3 |
| PB Ratio | -2.19 |
| P/FCF Ratio | 26.69 |
| PEG Ratio | n/a |
Enterprise Valuation
Core Scientific Inc. has an Enterprise Value (EV) of -.
| EV / Earnings | null |
| EV / Sales | null |
| EV / EBITDA | null |
| EV / EBIT | null |
| EV / FCF | null |
Financial Position
The company has a current ratio of 0.2, with a Debt / Equity ratio of -1.39.
| Current Ratio | 0.2 |
| Quick Ratio | 0.21 |
| Debt / Equity | -1.39 |
| Total Debt / Capitalization | 358.03 |
| Cash Flow / Debt | 0.08 |
| Interest Coverage | 0.1 |
Financial Efficiency
Return on equity (ROE) is 0.41% and return on capital (ROIC) is 3.35%.
| Return on Equity (ROE) | 0.41% |
| Return on Assets (ROA) | -0.35% |
| Return on Capital (ROIC) | 3.35% |
| Revenue Per Employee | 1.76M |
| Profits Per Employee | -861.84K |
| Employee Count | 286 |
| Asset Turnover | 0.71 |
| Inventory Turnover | -61.54 |
Taxes
| Income Tax | 683.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 0, so Core Scientific 's price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 14.9 |
| 200-Day Moving Average | 9.14 |
| Relative Strength Index (RSI) | 46.3 |
| Average Volume (20 Days) | 10.87M |
Income Statement
In the last 12 months, Core Scientific had revenue of $502.40M and earned -$246.49M in profits. Earnings per share was $-0.65.
| Revenue | 502.40M |
| Gross Profit | 123.46M |
| Operating Income | 8.96M |
| Net Income | -246.49M |
| EBITDA | -63.12M |
| EBIT | 8.96M |
| Earnings Per Share (EPS) | -0.65 |
Balance Sheet
The company has $50.41M in cash and $865.54M in debt, giving a net cash position of -$815.14M.
| Cash & Cash Equivalents | 50.41M |
| Total Debt | 865.54M |
| Net Cash | -815.14M |
| Retained Earnings | -2.42B |
| Total Assets | 921.85M |
| Working Capital | 201.34M |
Cash Flow
In the last 12 months, operating cash flow was $65.11M and capital expenditures -$16.16M, giving a free cash flow of $48.95M.
| Operating Cash Flow | 65.11M |
| Capital Expenditures | -16.16M |
| Free Cash Flow | 48.95M |
| FCF Per Share | 0.13 |
Margins
Gross margin is 24.57%, with operating and profit margins of 1.78% and -49.06%.
| Gross Margin | 24.57% |
| Operating Margin | 1.78% |
| Pretax Margin | -48.93% |
| Profit Margin | -49.06% |
| EBITDA Margin | -12.56% |
| EBIT Margin | 1.78% |
| FCF Margin | 9.74% |
Dividends & Yields
CORZ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -4.17% |
| FCF Yield | 1.12% |
Analyst Forecast
The average price target for CORZ is $18, which is 15.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $18 |
| Price Target Difference | 15.5% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
Scores
| Altman Z-Score | -6.82 |
| Piotroski F-Score | 6 |